Press release
Leading Companies Fueling Growth and Innovation in the Non-Steroidal Anti-inflammatory Drugs Market
Non-Steroidal Anti-inflammatory Drugs Market
Forecasted Market Size and Growth of the Non-Steroidal Anti-inflammatory Drugs Market
The NSAIDs market is projected to grow steadily, reaching a valuation of $29.96 billion by 2030. This reflects a compound annual growth rate (CAGR) of 6.5% during the forecast period. Several factors are driving this growth, including the increasing adoption of personalized medicine approaches, the rapid expansion of e-pharmacy platforms, ongoing research and development in novel NSAID formulations, a rising prevalence of chronic inflammatory diseases, and the integration of digital health technologies for pain monitoring. Key trends likely to influence the market include tailored pain management solutions, a surge in demand for over-the-counter (OTC) anti-inflammatory drugs, the development of fast-acting formulations, a strong focus on managing chronic pain and arthritis, and the growing footprint of online pharmacy distribution channels.
Download a free sample of the non-steroidal anti-inflammatory drugs market sample:
https://www.thebusinessresearchcompany.com/sample.aspx?id=8023&type=smp&utm_source=OpenPR&utm_medium=Paid&utm_campaign=Apr_PR
Leading Companies Influencing the Non-Steroidal Anti-inflammatory Drugs Market
The NSAIDs market features several prominent pharmaceutical players who have a major influence on its dynamics. These include Pfizer Inc., Bayer AG, Johnson & Johnson, Sun Pharmaceutical Industries Ltd., Assertio Therapeutics Inc., Iroko Pharmaceuticals Inc., Perrigo Company PLC, Hikma Pharmaceuticals PLC, Glenmark Pharmaceuticals Limited, Aspen Pharmacare Holdings Limited, Sagent Pharmaceuticals Inc., Advanced Pharma Inc., Akorn Operating Company LLC, Alembic Pharmaceuticals Limited, Torrent Pharmaceuticals Limited, Lupin Limited, Cipla Limited, Zydus Cadila Healthcare Limited, Aurobindo Pharma Limited, Sanofi S.A., GlaxoSmithKline PLC, Horizon Therapeutics PLC, Novartis AG, Roche Holding AG, AbbVie Inc., and Bristol-Myers Squibb Company. These companies continue to innovate and expand their product offerings to stay competitive in this growing market.
Innovative Trends Shaping the Future of NSAIDs - Part One
A key trend gaining traction in the NSAIDs market is the development of advanced combination therapies. Pharmaceutical companies are focusing on formulating analgesic-gastroprotective products to address gastrointestinal side effects commonly linked with long-term NSAID use. These combination drugs pair an NSAID with a protective agent that helps maintain anti-inflammatory benefits while reducing the risk of stomach irritation and ulcers. This innovation aims to provide safer pain relief options for patients requiring chronic treatment.
View the full non-steroidal anti-inflammatory drugs market report:
https://www.thebusinessresearchcompany.com/report/non-steroidal-anti-inflammatory-drugs-global-market-report?utm_source=OpenPR&utm_medium=Paid&utm_campaign=Apr_PR
Innovative Trends Shaping the Future of NSAIDs - Part Two
For example, in March 2024, Endo International plc, based in Ireland, introduced ibuprofen-famotidine 800 mg/26.6 mg tablets. This formulation combines the pain-relieving and anti-inflammatory effects of ibuprofen with the gastroprotective properties of famotidine. The dual-action tablet is designed to alleviate pain effectively while minimizing gastrointestinal side effects, enhancing patient safety and compliance. This development highlights the sector's commitment to improving therapeutic outcomes and reducing adverse effects.
Detailed Segment Breakdown of the Non-Steroidal Anti-inflammatory Drugs Market
The NSAIDs market is segmented in various ways to address different patient needs and distribution channels. By route of administration, the market includes oral forms, topical products, and other methods. Oral products are further divided into tablets, capsules, and liquids or solutions. Topical applications consist of gels, creams, and patches, while other administration routes cover injectables (both intravenous and intramuscular) and suppositories.
From a disease indication perspective, NSAIDs are used for arthritis, migraine, ophthalmic diseases, and other conditions. Distribution channels encompass hospital pharmacies, retail pharmacies, and online pharmacies, reflecting the diverse ways patients access these medications globally.
Reach out to us:
The Business Research Company: https://www.thebusinessresearchcompany.com/,
Americas +1 310-496-7795,
Europe +44 7882 955267,
Asia & Others +44 7882 955267 & +91 8897263534,
Email us at info@tbrc.info.
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Learn More About The Business Research Company
With over 17500+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.Our flagship product, the Global Market Model (GMM), is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Leading Companies Fueling Growth and Innovation in the Non-Steroidal Anti-inflammatory Drugs Market here
News-ID: 4499568 • Views: …
More Releases from The Business Research Company
Percutaneous Puncture Surgery Robot Market Analysis Highlights Growth To $3.54 B …
The market for percutaneous puncture surgery robots is on the verge of significant expansion, driven by rapid technological advances and increasing adoption in healthcare settings. As robotic systems become more sophisticated and integrated with cutting-edge technologies, this sector is set to transform minimally invasive surgical procedures. Below is a detailed exploration of the market's size, key players, trends, and segmentation that shape its future trajectory.
Projected Growth and Market Size of…
Pedicle Screw Systems Market Study Highlights How Industry Demand Is Evolving
The pedicle screw systems market is set to experience significant expansion in the coming years, driven by advancements in spinal surgery techniques and increasing patient demand. This market's evolution reflects growing medical needs and ongoing innovation, positioning it for substantial growth by 2030.
Forecasted Market Size and Growth Trajectory for Pedicle Screw Systems
The value of the pedicle screw systems market is projected to reach $7.65 billion by 2030, growing…
Pediatric Orthopedic Implants Market Research Reveals Strong 10.8% CAGR Outlook …
The pediatric orthopedic implants market is on track for significant expansion as advancements in technology and growing healthcare needs drive demand. Innovations in implant design and personalized treatment options are setting the stage for transformative growth in this specialized segment of medical devices. Below is a detailed overview of the current market size, key industry players, emerging trends, and segmentation that define this market's future.
Pediatric Orthopedic Implants Market Size and…
Pediatric Interventional Cardiology Market Intelligence Report Covers Trends, Se …
The pediatric interventional cardiology field is on track for significant expansion, driven by advances in medical technology and growing demand for specialized cardiac care for children. This sector is expected to see dynamic growth as innovative devices and techniques become more widely adopted to improve patient outcomes.
Projected Market Size and Growth Trajectory of the Pediatric Interventional Cardiology Market
The market for pediatric interventional cardiology is forecasted to grow steadily,…
More Releases for NSAID
NSAID-Acetaminophen Combination Analgesic Market Strategic Growth Drivers and Ou …
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global NSAID-Acetaminophen Combination Analgesic Market Size, Share & Trends Analysis Report By Type (OTC Combination Analgesics, Topical Combos, Liquid & Pediatric Formulations, Prescription Combo Formulations, and Others), Application (Acute Pain & Headache, Fever & Symptomatic Relief, Musculoskeletal Pain, and Post-op & Dental Pain), End-user (Retail Pharmacies, E-commerce, Hospital Pharmacies, Supermarkets & Mass Market, and Others),-Market Outlook…
NSAID API Market, Strategic Developments, Demand Surge in Chronic Pain Treatment …
Overview of the NSAID API Market
The global NSAID (Nonsteroidal Anti-inflammatory Drug) Active Pharmaceutical Ingredients (API) market is witnessing significant momentum, primarily driven by increasing incidences of chronic pain, arthritis, and inflammatory diseases worldwide. These APIs serve as the core components in formulating a wide range of prescription and over-the-counter analgesic medications. As the burden of non-communicable diseases rises globally, especially among the aging population, the demand for NSAID-based treatments has…
NSAID Ophthalmic Drugs Latest Market Analysis Report 2025
On Mar 12, 2025, Global Info Research released a research report titled "Global NSAID Ophthalmic Drugs Market 2025 by Manufacturers, Regions, Type and Application, Forecast to 2031". This report provides detailed data analysis of the NSAID Ophthalmic Drugs market from 2020 to 2031. Including the market size and development trends of NSAID Ophthalmic Drugs Market, it analyzes market size indicators such as sales, sales volume, average price and CAGR, it…
Global NSAID Ophthalmic Drugs Market Analysis By Major Manufacturers and Competi …
Globally, NSAID Ophthalmic Drugs key manufacturers include AbbVie, Bausch Health, Bayer, Dossa Pharmaceuticals, GlaxoSmithKline, Janssen Pharmaceuticals, Novartis, Pfizer and Sun Pharmaceutical Industries, etc. AbbVie, Bausch Health, Bayer are top 3 players and held % sales share in total in 2022
Global NSAID Ophthalmic Drugs Market: Driven factors and Restrictions factors
The research report encompasses a comprehensive analysis of the factors that affect the growth of the market. It includes an evaluation of…
Non-steroidal Anti-inflammatory Drugs (NSAID) Market Will Escalate Rapidly In Th …
Global Non-steroidal Anti-inflammatory Drugs (NSAID) Market 2022 research report initially provides a basic overview of the Market that covers definition, applications and manufacturing technology, post which the report explores into the international players in the market.
Request sample pages of this research study at -
https://www.theinsightpartners.com/sample/TIPRE00004421/?utm_source=OpenPR&utm_medium=10366
The non-steroidal anti-inflammatory drugs are a type of pain reliever that help to reduce inflammation and lower fevers. The NSAIDs are the most prescribed medications, which are…
Global NSAID API Market Size,Depth Research Report 2022-2028|Novartis, Pfizer, B …
Global Market For NSAID API Estimated At US$ Million In The Year 2022, Is Projected To Reach A Revised Size Of US$ Million By 2028, Growing At A CAGR Of % During The Forecast Period 2022-2028.
Los Angeles, United States October 2022,- The research study presented here is a brilliant compilation of different types of analysis of critical aspects of the global NSAID API market. It sheds light on how the…
